Angela Merkel – Swedes under 65 to be given alternative to AstraZeneca vaccine for second dose
Sweden paused the use of the AstraZeneca vaccine in March after reports of rare but serious blood clots among people vaccinated with the AstraZeneca shot. Sweden later resumed use but only for people aged 65 or above.
“People under the age of 65 who have already received a dose of Vaxzevria should instead be offered a second dose of so-called mRNA vaccine, such as PfizerBiontech or Moderna,” the Health Agency said in a statement.
Our Standards: The Thomson Reuters Trust Principles.